Recruitment

Recruitment Status
Completed

Inclusion Criteria

Patient agrees not to use hormonal contraception or any other medical intervention for bleeding during the study
Refractory menorrhagia with no definable organic cause (abnormal uterine bleeding)
Premenopausal at enrollment as determined by FSH measurement ≤ 40 IU/ml
...
Patient agrees not to use hormonal contraception or any other medical intervention for bleeding during the study
Refractory menorrhagia with no definable organic cause (abnormal uterine bleeding)
Premenopausal at enrollment as determined by FSH measurement ≤ 40 IU/ml
had at least 3 prior months documented failed medical therapy; or
refused medical therapy
had a contraindication to medical therapy; or
Uterine sound measurement of 6.0cm to 10.0cm (external os to internal fundus)
Able to provide written informed consent using a form that has been approved by the reviewing IRB/EC
Female subject from age 35 to 50 years
Not pregnant and no desire to conceive at any time
Subject agrees to follow-up exams and data collection, including ability to accurately use menstrual diaries
Subject who is literate or demonstrates an understanding on how to use menstrual diaries

Exclusion Criteria

Complex endometrial hyperplasia as confirmed by histology
Subject currently on hormonal birth control therapy or unwilling to use a non-hormonal birth control post-ablation.
Presence of bacteremia, sepsis, or other active systemic infection
...
Complex endometrial hyperplasia as confirmed by histology
Subject currently on hormonal birth control therapy or unwilling to use a non-hormonal birth control post-ablation.
Presence of bacteremia, sepsis, or other active systemic infection
Any subject who is participating in any other research of an investigational drug or device that has not yet completed the primary endpoint evaluation.
Known/suspected gynecological malignancy within the past 5 years
Septate or bicornuate uterus or other congenital malformation of the uterine cavity
Intramural or subserosal myomas that distort the uterine cavity
Prior uterine surgery (except low segment cesarean section) that interrupts the integrity of the uterine wall (e.g., transmural myomectomy or classical cesarean section)
Currently on anticoagulants
Presence of an intrauterine device (IUD)
Untreated/unevaluated cervical dysplasia
Any general health condition which, in the opinion of the Investigator, could represent an increased risk for the subject
Active infection of the genitals, vagina, cervix, uterus or urinary tract at the time of the procedure
Active pelvic inflammatory disease
Pedunculated or submucosal myomas distorting the uterine cavity
Currently on medications that could thin the myometrial muscle, such as long-term steroid use
Pregnancy or subject with a desire to conceive
Presence of active endometritis
Active sexually transmitted disease (STD)
Polyps likely to be the cause of the subject's menorrhagia
Known/suspected abdominal/pelvic cancer
Previous endometrial ablation procedure
Known clotting defects or bleeding disorders

Summary

Conditions
Menorrhagia Due to Benign Causes
Type
Interventional
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 35 years and 50 years
Gender
Only females

Inclusion Criteria

Patient agrees not to use hormonal contraception or any other medical intervention for bleeding during the study
Refractory menorrhagia with no definable organic cause (abnormal uterine bleeding)
Premenopausal at enrollment as determined by FSH measurement ≤ 40 IU/ml
...
Patient agrees not to use hormonal contraception or any other medical intervention for bleeding during the study
Refractory menorrhagia with no definable organic cause (abnormal uterine bleeding)
Premenopausal at enrollment as determined by FSH measurement ≤ 40 IU/ml
had at least 3 prior months documented failed medical therapy; or
refused medical therapy
had a contraindication to medical therapy; or
Uterine sound measurement of 6.0cm to 10.0cm (external os to internal fundus)
Able to provide written informed consent using a form that has been approved by the reviewing IRB/EC
Female subject from age 35 to 50 years
Not pregnant and no desire to conceive at any time
Subject agrees to follow-up exams and data collection, including ability to accurately use menstrual diaries
Subject who is literate or demonstrates an understanding on how to use menstrual diaries

Exclusion Criteria

Complex endometrial hyperplasia as confirmed by histology
Subject currently on hormonal birth control therapy or unwilling to use a non-hormonal birth control post-ablation.
Presence of bacteremia, sepsis, or other active systemic infection
...
Complex endometrial hyperplasia as confirmed by histology
Subject currently on hormonal birth control therapy or unwilling to use a non-hormonal birth control post-ablation.
Presence of bacteremia, sepsis, or other active systemic infection
Any subject who is participating in any other research of an investigational drug or device that has not yet completed the primary endpoint evaluation.
Known/suspected gynecological malignancy within the past 5 years
Septate or bicornuate uterus or other congenital malformation of the uterine cavity
Intramural or subserosal myomas that distort the uterine cavity
Prior uterine surgery (except low segment cesarean section) that interrupts the integrity of the uterine wall (e.g., transmural myomectomy or classical cesarean section)
Currently on anticoagulants
Presence of an intrauterine device (IUD)
Untreated/unevaluated cervical dysplasia
Any general health condition which, in the opinion of the Investigator, could represent an increased risk for the subject
Active infection of the genitals, vagina, cervix, uterus or urinary tract at the time of the procedure
Active pelvic inflammatory disease
Pedunculated or submucosal myomas distorting the uterine cavity
Currently on medications that could thin the myometrial muscle, such as long-term steroid use
Pregnancy or subject with a desire to conceive
Presence of active endometritis
Active sexually transmitted disease (STD)
Polyps likely to be the cause of the subject's menorrhagia
Known/suspected abdominal/pelvic cancer
Previous endometrial ablation procedure
Known clotting defects or bleeding disorders

Locations

Debrecen, Hajdú-Bihar, 4043
Szeged, Csongrad, 6725
Budapest, 1115
Debrecen, Hajdú-Bihar, 4043
Szeged, Csongrad, 6725
Budapest, 1115

Tracking Information

NCT #
NCT02035332
Collaborators
Not Provided
Investigators
Not Provided